List of Tables
Table 1. Ophthalmic Drugs Market Trends
Table 2. Ophthalmic Drugs Market Drivers & Opportunity
Table 3. Ophthalmic Drugs Market Challenges
Table 4. Ophthalmic Drugs Market Restraints
Table 5. Global Ophthalmic Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Ophthalmic Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Ophthalmic Drugs Sales Volume by Company (2019-2024) & (K MT)
Table 8. Global Ophthalmic Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Ophthalmic Drugs Price by Company (2019-2024) & (USD/MT)
Table 10. Key Manufacturers Ophthalmic Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Ophthalmic Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Ophthalmic Drugs
Table 13. Global Ophthalmic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Ophthalmic Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Ophthalmic Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Ophthalmic Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Ophthalmic Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Ophthalmic Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Ophthalmic Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
Table 22. Global Ophthalmic Drugs Sales Volume by Type (2019-2024) & (K MT)
Table 23. Global Ophthalmic Drugs Sales Volume by Type (2025-2030) & (K MT)
Table 24. Global Ophthalmic Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Ophthalmic Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Ophthalmic Drugs Price by Type (2019-2024) & (USD/MT)
Table 27. Global Ophthalmic Drugs Price by Type (2025-2030) & (USD/MT)
Table 28. Global Ophthalmic Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Ophthalmic Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Ophthalmic Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Ophthalmic Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Ophthalmic Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Ophthalmic Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
Table 34. Global Ophthalmic Drugs Sales Volume by Application (2019-2024) & (K MT)
Table 35. Global Ophthalmic Drugs Sales Volume by Application (2025-2030) & (K MT)
Table 36. Global Ophthalmic Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Ophthalmic Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Ophthalmic Drugs Price by Application (2019-2024) & (USD/MT)
Table 39. Global Ophthalmic Drugs Price by Application (2025-2030) & (USD/MT)
Table 40. Global Ophthalmic Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Ophthalmic Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Ophthalmic Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Ophthalmic Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Ophthalmic Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Ophthalmic Drugs Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
Table 46. Global Ophthalmic Drugs Sales Volume by Region (2019-2024) & (K MT)
Table 47. Global Ophthalmic Drugs Sales Volume by Region (2025-2030) & (K MT)
Table 48. Global Ophthalmic Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Ophthalmic Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Ophthalmic Drugs Average Price by Region (2019-2024) & (USD/MT)
Table 51. Global Ophthalmic Drugs Average Price by Region (2025-2030) & (USD/MT)
Table 52. Key Countries/Regions Ophthalmic Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Ophthalmic Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Ophthalmic Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Ophthalmic Drugs Sales Volume, (2019-2024) & (K MT)
Table 56. Key Countries/Regions Ophthalmic Drugs Sales Volume, (2025-2030) & (K MT)
Table 57. Santen Pharmaceutical Company Information
Table 58. Santen Pharmaceutical Introduction and Business Overview
Table 59. Santen Pharmaceutical Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 60. Santen Pharmaceutical Ophthalmic Drugs Product Offerings
Table 61. Santen Pharmaceutical Recent Development
Table 62. Bausch Health Company Information
Table 63. Bausch Health Introduction and Business Overview
Table 64. Bausch Health Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 65. Bausch Health Ophthalmic Drugs Product Offerings
Table 66. Bausch Health Recent Development
Table 67. Takeda Company Information
Table 68. Takeda Introduction and Business Overview
Table 69. Takeda Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 70. Takeda Ophthalmic Drugs Product Offerings
Table 71. Takeda Recent Development
Table 72. Novartis Company Information
Table 73. Novartis Introduction and Business Overview
Table 74. Novartis Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 75. Novartis Ophthalmic Drugs Product Offerings
Table 76. Novartis Recent Development
Table 77. Genentech Company Information
Table 78. Genentech Introduction and Business Overview
Table 79. Genentech Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 80. Genentech Ophthalmic Drugs Product Offerings
Table 81. Genentech Recent Development
Table 82. Allergan Company Information
Table 83. Allergan Introduction and Business Overview
Table 84. Allergan Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 85. Allergan Ophthalmic Drugs Product Offerings
Table 86. Allergan Recent Development
Table 87. Sun Pharmaceutical Industries Company Information
Table 88. Sun Pharmaceutical Industries Introduction and Business Overview
Table 89. Sun Pharmaceutical Industries Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 90. Sun Pharmaceutical Industries Ophthalmic Drugs Product Offerings
Table 91. Sun Pharmaceutical Industries Recent Development
Table 92. Actavis Generics Company Information
Table 93. Actavis Generics Introduction and Business Overview
Table 94. Actavis Generics Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 95. Actavis Generics Ophthalmic Drugs Product Offerings
Table 96. Actavis Generics Recent Development
Table 97. Regeneron Pharmaceuticals Company Information
Table 98. Regeneron Pharmaceuticals Introduction and Business Overview
Table 99. Regeneron Pharmaceuticals Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 100. Regeneron Pharmaceuticals Ophthalmic Drugs Product Offerings
Table 101. Regeneron Pharmaceuticals Recent Development
Table 102. Pfizer Company Information
Table 103. Pfizer Introduction and Business Overview
Table 104. Pfizer Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 105. Pfizer Ophthalmic Drugs Product Offerings
Table 106. Pfizer Recent Development
Table 107. Johnson and Johnson Company Information
Table 108. Johnson and Johnson Introduction and Business Overview
Table 109. Johnson and Johnson Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 110. Johnson and Johnson Ophthalmic Drugs Product Offerings
Table 111. Johnson and Johnson Recent Development
Table 112. Bausch and Lomb Company Information
Table 113. Bausch and Lomb Introduction and Business Overview
Table 114. Bausch and Lomb Ophthalmic Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 115. Bausch and Lomb Ophthalmic Drugs Product Offerings
Table 116. Bausch and Lomb Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Ophthalmic Drugs Downstream Customers
Table 120. Ophthalmic Drugs Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophthalmic Drugs Product Picture
Figure 2. Global Ophthalmic Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Ophthalmic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Ophthalmic Drugs Sales Volume (2019-2030) & (K MT)
Figure 5. Global Ophthalmic Drugs Sales Price (2019-2030) & (USD/MT)
Figure 6. Ophthalmic Drugs Report Years Considered
Figure 7. Global Ophthalmic Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Ophthalmic Drugs Players Sales Volume Ranking (2023) & (K MT)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Ophthalmic Drugs Revenue in 2023
Figure 10. Ophthalmic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Anti-allergy Picture
Figure 12. Anti-VEGF Agents Picture
Figure 13. Anti-inflammatory Picture
Figure 14. Anti-glaucoma Picture
Figure 15. Global Ophthalmic Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Ophthalmic Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Ophthalmic Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
Figure 18. Global Ophthalmic Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Ophthalmic Drugs Price by Type (2019-2030) & (USD/MT)
Figure 20. Product Picture of Hospital
Figure 21. Product Picture of Clinic
Figure 22. Product Picture of Pharmacy
Figure 23. Global Ophthalmic Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Ophthalmic Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Ophthalmic Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
Figure 26. Global Ophthalmic Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Ophthalmic Drugs Price by Application (2019-2030) & (USD/MT)
Figure 28. North America Ophthalmic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Ophthalmic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Ophthalmic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Ophthalmic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Ophthalmic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Ophthalmic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Ophthalmic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Ophthalmic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Ophthalmic Drugs Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Ophthalmic Drugs Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Ophthalmic Drugs Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Ophthalmic Drugs Sales Volume (%), (2019-2030)
Figure 40. United States Ophthalmic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Ophthalmic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Ophthalmic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Ophthalmic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Ophthalmic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Ophthalmic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 46. China Ophthalmic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Ophthalmic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 48. China Ophthalmic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Ophthalmic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Ophthalmic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Ophthalmic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Ophthalmic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Ophthalmic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Ophthalmic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Ophthalmic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Ophthalmic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Ophthalmic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 58. India Ophthalmic Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Ophthalmic Drugs Sales Value by Type (%), 2023 VS 2030
Figure 60. India Ophthalmic Drugs Sales Value by Application (%), 2023 VS 2030
Figure 61. Ophthalmic Drugs Industrial Chain
Figure 62. Ophthalmic Drugs Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
